- Home
- MSGE vs MNKD Comparison
MSGE vs MNKD Comparison
Compare MSGE & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- MNKD
- Stock Information
- Founded
- MSGE 2020
- MNKD 1991
- Country
- MSGE United States
- MNKD United States
- Employees
- MSGE N/A
- MNKD N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- MSGE Consumer Discretionary
- MNKD Health Care
- Exchange
- MSGE Nasdaq
- MNKD Nasdaq
- Market Cap
- MSGE 2.1B
- MNKD 1.8B
- IPO Year
- MSGE N/A
- MNKD 2004
- Fundamental
- Price
- MSGE $36.44
- MNKD $6.80
- Analyst Decision
- MSGE Strong Buy
- MNKD Strong Buy
- Analyst Count
- MSGE 5
- MNKD 5
- Target Price
- MSGE $46.00
- MNKD $8.40
- AVG Volume (30 Days)
- MSGE 378.1K
- MNKD 2.9M
- Earning Date
- MSGE 11-08-2024
- MNKD 11-07-2024
- Dividend Yield
- MSGE N/A
- MNKD N/A
- EPS Growth
- MSGE 330.95
- MNKD N/A
- EPS
- MSGE 3.66
- MNKD 0.08
- Revenue
- MSGE $955,767,000.00
- MNKD $267,200,000.00
- Revenue This Year
- MSGE $4.45
- MNKD $46.83
- Revenue Next Year
- MSGE $5.29
- MNKD $14.40
- P/E Ratio
- MSGE $9.95
- MNKD $85.77
- Revenue Growth
- MSGE 12.81
- MNKD 51.35
- 52 Week Low
- MSGE $29.71
- MNKD $3.17
- 52 Week High
- MSGE $44.14
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- MSGE 30.83
- MNKD 47.15
- Support Level
- MSGE $37.31
- MNKD $6.61
- Resistance Level
- MSGE $44.14
- MNKD $7.44
- Average True Range (ATR)
- MSGE 1.25
- MNKD 0.35
- MACD
- MSGE -0.69
- MNKD -0.05
- Stochastic Oscillator
- MSGE 10.31
- MNKD 18.63
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.